CTH1 Antibody

What is CTH and why is it important in biological research?

CTH (Cystathionase) is a key enzyme in the transsulfuration pathway that converts cystathionine to cysteine. It belongs to the transsulfuration enzymes family and catalyzes the last step in the pathway from methionine to cysteine. Beyond this role, CTH is the major H₂S-producing enzyme in kidney, liver, vascular smooth muscle cells, and enterocytes . The endogenous production of H₂S plays significant roles in regulating cellular functions, including cell growth, membrane hyperpolarization, neuronal excitability modulation, and smooth muscle cell relaxation . Mutations in the CTH gene can result in cystathioninuria, an autosomal recessive disorder characterized by unusual accumulation of plasma cystathionine causing increased urinary excretion . Research using CTH antibodies has revealed its importance in cardiovascular health, inflammation, and redox signaling pathways.

Selecting appropriate positive controls is crucial for validating CTH antibody performance. Based on published results, the following samples consistently show CTH expression:

Additionally, human vascular smooth muscle cells (HASMCs) have been reported to express CTH and are frequently used in cardiovascular research applications .

How does CTH molecular weight appear on Western blots?

• A minor band at approximately 36 kDa may be observed, particularly in vitamin B6-deficient rat liver samples, likely representing a degradative intermediate .

• Some studies have reported detection of CTH at approximately 70 kDa in rat liver samples .

• When using recombinant GST-tagged CTH, the observed molecular weight may be higher (approximately 70.07 kDa) due to the GST tag (26 kDa) .

These variations highlight the importance of including appropriate positive controls when establishing Western blot protocols with CTH antibodies.

What are the optimal antigen retrieval methods for CTH immunohistochemistry?

For optimal CTH detection in immunohistochemistry applications, antigen retrieval methods significantly impact staining quality and specificity. The following protocols have been validated:

• Primary recommendation: TE buffer pH 9.0

• Alternative method: Citrate buffer pH 6.0

How can CTH antibodies be validated for specificity?

Validating antibody specificity is critical for ensuring experimental reliability. Multiple approaches are recommended:

• Knockout/Knockdown verification: Several publications have utilized CTH knockout models or siRNA knockdown approaches to validate antibody specificity. CTH-null mice exhibit hypercystathioninemia and hyperhomocysteinemia, providing a valuable negative control for antibody testing .

• Western blot validation using recombinant protein: Compare CTH transfected lysate (showing predicted band at 44.5 kDa) against non-transfected lysate (negative control) .

• Cross-reactivity assessment: CTH antibodies have confirmed reactivity with human, mouse, and rat samples. Some antibodies have also shown reactivity with pig and rabbit samples .

• Correlative approach: Compare protein expression using multiple antibodies targeting different epitopes of CTH, or correlate protein expression with mRNA levels using RT-PCR.

What technical considerations are important when studying CTH's role in hydrogen sulfide (H₂S) production?

When investigating CTH's role in H₂S production, several methodological considerations are essential:

• Enzymatic activity vs. protein expression: CTH protein levels may not directly correlate with H₂S production rates. Consider using complementary assays to measure both protein levels (via antibody detection) and enzymatic activity.

• Tissue-specific expression patterns: CTH is the major H₂S-producing enzyme in kidney, liver, vascular smooth muscle cells, and enterocytes, but not in all tissues. Brain tissues predominantly utilize CBS for H₂S production .

• Experimental models: Several publications have used gene silencing approaches to inhibit CTH expression in studying inflammation. For example, inhibition of endogenous H₂S in RAW264.7 cells has been shown to attenuate inflammatory activity of LPS-activated cells .

• Temporal considerations: The CSE/H₂S pathway shows differential regulation during disease progression. In CVB3-induced myocarditis, inhibition of endogenous H₂S is beneficial early in disease, while administration of exogenous H₂S is protective during later stages .

Why might multiple bands appear when using CTH antibodies in Western blot?

Multiple bands when using CTH antibodies can result from several factors:

• Post-translational modifications: CTH undergoes regulatory modifications that may alter its apparent molecular weight.

• Alternative isoforms: While the primary band appears at 40-45 kDa, a secondary band at 36 kDa has been observed in vitamin B6-deficient samples, likely representing a degradative intermediate .

• Cross-reactivity: Some antibodies may detect proteins with similar epitopes, particularly at high concentrations. Dilution optimization is critical, with recommendations ranging from 1:5000 to 1:50000 for Western blot applications .

• Sample preparation issues: Protein degradation during sample preparation can produce fragments that are detected as multiple bands. Use fresh protease inhibitors and maintain cold conditions during preparation.

• Aggregation or oligomerization: Some studies have reported detection of CTH at approximately 70 kDa in rat liver samples, which may represent dimerization .

To address multiple band issues, verify with positive controls, optimize antibody dilution, improve sample preparation techniques, and consider alternative antibody clones if necessary.

What controls are essential when using CTH antibodies in various applications?

Including these controls helps distinguish between specific signal and experimental artifacts, particularly important when studying CTH in novel experimental contexts or tissues with variable expression levels.

How can background staining be reduced in immunohistochemistry and immunofluorescence applications?

High background staining can obscure specific CTH signals in IHC and IF applications. Consider these optimization strategies:

• Antibody titration: Test multiple dilutions within the recommended range (1:100-1:500 for IHC; 1:200-1:800 for IF) to determine the optimal signal-to-noise ratio.

• Blocking optimization: Extend blocking time or try alternative blocking agents (BSA, normal serum, commercial blockers) that match your sample type.

• Washing optimization: Increase the number or duration of washes between antibody incubations, using 0.05-0.1% Tween-20 in PBS to reduce non-specific binding.

• Antigen retrieval adjustment: Compare TE buffer pH 9.0 against citrate buffer pH 6.0 to determine which produces cleaner background while maintaining specific staining .

• Secondary antibody selection: Use highly cross-adsorbed secondary antibodies to minimize species cross-reactivity, particularly important in multi-color immunofluorescence.

• Endogenous peroxidase/phosphatase blocking: For IHC applications, ensure complete quenching of endogenous enzymes before antibody application.

How are CTH antibodies being utilized to study redox signaling and oxidative stress?

CTH plays a crucial role in regulating oxidative stress through its role in generating hydrogen sulfide and cysteine, both important for cellular redox homeostasis. Recent research applications include:

• Reactive cysteine persulfides and S-polythiolation: Studies have used CTH antibodies to investigate how CTH-derived H₂S contributes to persulfide formation and S-polythiolation, which regulate oxidative stress and redox signaling . These post-translational modifications are emerging as critical regulatory mechanisms for protein function.

• Mitochondrial stress responses: CTH antibodies have been employed to study the transsulfuration pathway's role in supporting cell growth under cysteine limitation and its contribution to mitochondrial integrated stress responses. This research has revealed CTH's involvement in mitochondrial myopathy progression .

• mTORC1 signaling interactions: Investigations utilizing CTH antibodies have uncovered connections between mTORC1 activity, cell growth, S-adenosylmethionine (SAM) synthesis, and m6A mRNA-dependent control of protein synthesis .

• One-carbon metabolism remodeling: CTH detection has been crucial in studies showing how mitochondrial DNA replication defects disturb cellular dNTP pools and remodel one-carbon metabolism .

What is known about CTH's role in inflammation and how are antibodies advancing this research?

CTH-generated H₂S has emerged as an important mediator in inflammatory processes. Key research developments include:

• Resolution of inflammation: CTH antibodies have been used to demonstrate that H₂S promotes resolution of inflammation in experimental colitis models. Both endogenous and exogenous H₂S have been shown to promote resolution of colitis in rats .

• Macrophage function: Immunofluorescence and immunohistochemistry with CTH antibodies have revealed expression patterns in human peripheral blood mononuclear cell-derived macrophages, helping elucidate H₂S's role in acute inflammation resolution .

• LPS-activated inflammatory responses: Gene silencing studies combined with CTH antibody detection have demonstrated that inhibition of hydrogen sulfide production attenuates inflammatory activity in LPS-activated RAW264.7 cells .

• Gastrointestinal inflammation: CTH antibodies have enabled mapping of H₂S synthesis throughout the gastrointestinal tract, revealing tissue-specific expression patterns that contribute to understanding inflammatory bowel diseases .

How are CTH antibodies contributing to cardiovascular disease research?

CTH has significant implications for cardiovascular health through its production of H₂S, which affects vascular tone, inflammation, and cellular stress responses:

• Atherosclerosis progression: Studies utilizing CTH antibodies have demonstrated that decreased endogenous production of H₂S accelerates atherosclerosis development . The CSE/H₂S pathway is emerging as a potential therapeutic target for cardiovascular disease.

• Neointimal formation: CTH deficiency has been linked to increased neointimal formation, with CTH antibodies helping to elucidate the role of hydrogen sulfide in α5β1-integrin and matrix metalloproteinase-2 expression in smooth muscle cells .

• MicroRNA regulation: Research employing CTH antibodies has revealed that microRNA-21 represses human cystathionine gamma-lyase expression by targeting specificity protein-1 in smooth muscle cells , providing insight into post-transcriptional regulation of CTH.

• Smooth muscle cell function: CTH antibodies have been critical in identifying specificity protein-1 as a key regulator of CTH in smooth muscle cells, with implications for vascular reactivity and remodeling .

• Contractile function: Immunofluorescence studies with CTH antibodies have helped characterize CTH expression and function in rat jejunum, revealing its role in modulating contractile function .

What are the key specifications for commercially available CTH antibodies?

These specifications help researchers select the appropriate antibody based on their experimental requirements, target species, and intended applications .

What recent publications demonstrate successful application of CTH antibodies?

CTH antibodies have been utilized in numerous high-impact studies exploring diverse biological processes:

• Reactive cysteine persulfides and S-polythiolation research in oxidative stress regulation (PNAS 2014) .

• Investigation of hydrogen sulfide's role in inflammation using RAW264.7 cells (Applied Microbiology and Biotechnology 2013) .

• Studies on endogenous hydrogen sulfide production in atherosclerosis (Journal of Cellular Physiology 2012) .

• Analysis of hydrogen sulfide producing enzymes in pregnancy and preeclampsia (Placenta 2012) .

• Research on microRNA-21 regulation of CTH expression in smooth muscle cells (Journal of Cellular Physiology 2012) .

• Examination of hydrogen sulfide synthesis patterns in gastrointestinal tract (Digestive and Liver Disease 2010) .

• Studies on hydrogen sulfide's role in promoting resolution of colitis (Gastroenterology 2009) .

These publications demonstrate the versatility of CTH antibodies across different research areas and experimental approaches.

What emerging technologies might enhance CTH antibody applications in research?

Several technological advances are likely to expand the utility of CTH antibodies in research:

• Single-cell analysis: Integration of CTH antibodies into mass cytometry (CyTOF) or imaging mass cytometry could enable simultaneous detection of CTH alongside dozens of other proteins at single-cell resolution.

• Super-resolution microscopy: Application of techniques like STORM, PALM, or STED with CTH antibodies could reveal subcellular localization patterns with unprecedented detail.

• Proximity labeling approaches: Combining CTH antibodies with BioID or APEX2 proximity labeling systems could identify novel protein interaction partners.

• Intravital imaging: Development of non-perturbing fluorescently-labeled CTH antibody fragments for in vivo imaging could enable real-time tracking of CTH expression.

• Computational analysis: Machine learning approaches applied to large datasets of CTH expression patterns could reveal previously unrecognized correlations with disease states or physiological conditions.